Chesley Taft & Associates’s MetLife MET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.23M | Buy |
26,392
+2,202
| +9% | +$178K | 0.09% | 156 |
|
|
2026
Q1 | $1.71M | Sell |
24,190
-929
| -4% | -$69.6K | 0.07% | 171 |
|
|
2025
Q4 | $1.98M | Buy |
25,119
+3,471
| +16% | +$275K | 0.08% | 164 |
|
|
2025
Q3 | $1.78M | Buy |
21,648
+1,421
| +7% | +$112K | 0.08% | 164 |
|
|
2025
Q2 | $1.63M | Buy |
20,227
+1,199
| +6% | +$92.5K | 0.07% | 165 |
|
|
2025
Q1 | $1.53M | Buy |
19,028
+1,180
| +7% | +$98.1K | 0.07% | 167 |
|
|
2024
Q4 | $1.46M | Buy |
17,848
+218
| +1% | +$18.1K | 0.07% | 169 |
|
|
2024
Q3 | $1.45M | Buy |
17,630
+563
| +3% | +$42.1K | 0.07% | 165 |
|
|
2024
Q2 | $1.2M | Sell |
17,067
-112
| -0.7% | -$8K | 0.06% | 174 |
|
|
2024
Q1 | $1.27M | Buy |
17,179
+585
| +4% | +$40.8K | 0.07% | 169 |
|
|
2023
Q4 | $1.1M | Buy |
16,594
+804
| +5% | +$50.3K | 0.06% | 177 |
|
|
2023
Q3 | $993K | Buy |
15,790
+255
| +2% | +$15.9K | 0.06% | 177 |
|
|
2023
Q2 | $878K | Hold |
15,535
| – | – | 0.05% | 183 |
|
|
2023
Q1 | $900K | Hold |
15,535
| – | – | 0.06% | 182 |
|
|
2022
Q4 | $1.12M | Hold |
15,535
| – | – | 0.08% | 157 |
|
|
2022
Q3 | $944K | Hold |
15,535
| – | – | 0.07% | 166 |
|
|
2022
Q2 | $975K | Sell |
15,535
-30
| -0.2% | -$1.99K | 0.07% | 170 |
|
|
2022
Q1 | $1.09M | Buy |
15,565
+450
| +3% | +$30.4K | 0.06% | 175 |
|
|
2021
Q4 | $945K | Hold |
15,115
| – | – | 0.05% | 189 |
|
|
2021
Q3 | $933K | Hold |
15,115
| – | – | 0.05% | 182 |
|
|
2021
Q2 | $905K | Buy |
15,115
+100
| +0.7% | +$6.34K | 0.05% | 185 |
|
|
2021
Q1 | $925K | Hold |
15,015
| – | – | 0.06% | 177 |
|
|
2020
Q4 | $705K | Hold |
15,015
| – | – | 0.05% | 187 |
|
|
2020
Q3 | $558K | Sell |
15,015
-100
| -0.7% | -$3.8K | 0.04% | 194 |
|
|
2020
Q2 | $552K | Sell |
15,115
-200
| -1% | -$6.96K | 0.04% | 189 |
|
|
2020
Q1 | $468K | Hold |
15,315
| – | – | 0.04% | 189 |
|
|
2019
Q4 | $781K | Sell |
15,315
-500
| -3% | -$24.1K | 0.06% | 180 |
|
|
2019
Q3 | $746K | Buy |
15,815
+30
| +0.2% | +$1.43K | 0.06% | 179 |
|
|
2019
Q2 | $784K | Hold |
15,785
| – | – | 0.06% | 171 |
|
|
2019
Q1 | $672K | Sell |
15,785
-550
| -3% | -$24.3K | 0.06% | 184 |
|
|
2018
Q4 | $671K | Sell |
16,335
-1,750
| -10% | -$75.1K | 0.06% | 179 |
|
|
2018
Q3 | $845K | Hold |
18,085
| – | – | 0.07% | 181 |
|
|
2018
Q2 | $789K | Hold |
18,085
| – | – | 0.07% | 184 |
|
|
2018
Q1 | $830K | Sell |
18,085
-18,577
| -51% | -$901K | 0.07% | 178 |
|
|
2017
Q4 | $1.85M | Sell |
36,662
-198
| -0.5% | -$10.4K | 0.16% | 126 |
|
|
2017
Q3 | $1.92M | Sell |
36,860
-6,589
| -15% | -$321K | 0.17% | 125 |
|
|
2017
Q2 | $2.13M | Buy |
43,449
+611
| +1% | +$28.3K | 0.19% | 110 |
|
|
2017
Q1 | $2.02M | Buy |
42,838
+191
| +0.4% | +$9.11K | 0.19% | 110 |
|
|
2016
Q4 | $2.05M | Sell |
42,647
-157
| -0.4% | -$7.2K | 0.2% | 101 |
|
|
2016
Q3 | $1.7M | Sell |
42,804
-44,235
| -51% | -$1.66M | 0.17% | 114 |
|
|
2016
Q2 | $3.09M | Buy |
87,039
+2,559
| +3% | +$99.8K | 0.32% | 83 |
|
|
2016
Q1 | $3.31M | Sell |
84,480
-156,844
| -65% | -$5.86M | 0.35% | 81 |
|
|
2015
Q4 | $10.4M | Sell |
241,324
-44,317
| -16% | -$1.95M | 1.09% | 29 |
|
|
2015
Q3 | $12M | Buy |
285,641
+3,329
| +1% | +$156K | 1.31% | 23 |
|
|
2015
Q2 | $14.1M | Buy |
282,312
+11,865
| +4% | +$562K | 1.44% | 21 |
|
|
2015
Q1 | $12.2M | Buy |
270,447
+7,349
| +3% | +$330K | 1.25% | 23 |
|
|
2014
Q4 | $12.7M | Buy |
263,098
+10,957
| +4% | +$521K | 1.28% | 23 |
|
|
2014
Q3 | $12.1M | Buy |
252,141
+62,743
| +33% | +$3.05M | 1.26% | 23 |
|
|
2014
Q2 | $9.38M | Buy |
189,398
+120,984
| +177% | +$5.66M | 0.97% | 38 |
|
|
2014
Q1 | $3.22M | Buy |
68,414
+785
| +1% | +$36.1K | 0.34% | 83 |
|
|
2013
Q4 | $3.25M | Buy |
67,629
+27
| +0% | +$1.21K | 0.32% | 87 |
|
|
2013
Q3 | $2.83M | Buy |
67,602
+449
| +0.7% | +$19.3K | 0.31% | 90 |
|
|
2013
Q2 | $2.74M | Buy |
+67,153
| New | +$2.47M | 0.32% | 87 |
|
Other funds holding MET
AAMU
WCM
AV
FMII
P
FHC
OIAM
CNB
Chesley Taft & Associates's MET Position: Q2 2026 in Review
Chesley Taft & Associates increased its MetLife (MET) stake by 9.1% in Q2 2026, buying an estimated $178K and bringing the position to 26,392 shares worth $2.23M. The position accounts for 0.09% of the portfolio, ranked #156.
Chesley Taft & Associates first reported a position in MET in Q2 2013 and has held it in 53 quarters since. The position peaked at $14.1M in Q2 2015. 253 funds tracked by Wall St. Rank hold MET as of Q2 2026.
- Chesley Taft & Associates held 26,392 shares of MetLife worth $2.23M as of Q2 2026.
- Chesley Taft & Associates bought 2,202 MetLife shares in Q2 2026, an estimated $178K.
- MetLife made up 0.09% of Chesley Taft & Associates's portfolio in Q2 2026, its #156 holding.
- Chesley Taft & Associates first reported a position in MetLife in Q2 2013 and has held it in 53 quarters since.
- Chesley Taft & Associates's MetLife position peaked at $14.1M in Q2 2015.
- 253 funds tracked by Wall St. Rank held MetLife as of Q2 2026.
Based on Chesley Taft & Associates's 13F filing for Q2 2026, filed 8 Jul 2026.